Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma.

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

March 30, 2021

Conditions
Evaluate the Cost of a PIPAC Procedure and the Associated Hospital Stay in France
Interventions
PROCEDURE

PIPAC

"under general anaesthesia, a laparoscopy was performed using an open laparoscopic technique to prevent intestinal wounds, which would contraindicate the procedure. A 12 mmHg pneumoperitoneum was created, and to ensure the safety of the procedure the pressure of the pneumoperitoneum was maintained constant throughout the procedure. Two laparoscopic balloon trocars (of 11 and 12 mm) were used. A thorough exploration of the abdomen, Peritoneal Cancer Index assessment, images, peritoneal biopsies, and ascites cytology (in the case of ascites) were performed prior to administration of the chemotherapy aerosol.~For carcinomas of gastric origin, Doxurubicin at a dose of 1.5 mg/m2 was administered in combination with Cisplatin 7.5 mg/m2 diluted in 40 and 150 mL of 0.9% sodium chloride, respectively. In the case of contraindication, Oxaliplatine at a dose of 92 mg/m2 in a 5% dextrose solution was recommended."

Trial Locations (1)

Unknown

CHUGA, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT04779385 - Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma. | Biotech Hunter | Biotech Hunter